Offering New Hope for Patients with Advanced Alveolar Soft Part Sarcoma

This study looks at how well a medicine called Anlotinib works for treating advanced alveolar soft part sarcoma. The main goal is to see if this treatment is safe and effective. Currently, only patients with alveolar soft part sarcoma can join the study, as recruitment for other types has ended.